Scientific Reports 6: Article number: 29487; published online: 12 July 2016; updated: 25 August 2016
In this Article, Figure 3 is incorrect. The correct Figure 3 appears below as Figure 1. As a result, the accompanying legend should read:
Figure 1
“Antiviral activity on a replicon cell line. Huh-J17 cells expressing the N17/JFH1 subgenomic replicon were seeded in the presence of the drugs at the concentration of 10 μM each, or an equivalent amount of DMSO as a vehicle control, and then incubated at 37 °C for 24 h, 48 h or 72 h. The cells were then lysed and the luciferase activity (the level of which correlates directly with that of viral RNA replication) determined as described in Materials and Methods. In parallel, cell viability was measured at 72 h post-incubation. Data are presented as % activity (i.e. % inhibition of virus RNA replication or % cell viability) relative to that of DMSO-treated cells, which is represented as 100%”.
Additional information
The online version of the original article can be found at 10.1038/srep29487
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Magri, A., Ozerov, A., Tunitskaya, V. et al. Correction: Corrigendum: Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication. Sci Rep 6, 31529 (2016). https://doi.org/10.1038/srep31529
Published:
DOI: https://doi.org/10.1038/srep31529
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
